Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Syndax Pharmaceuticals, Inc. | SNDX | 8.05M | $175.99M |
Viridian Therapeutics, Inc. | VRDN | 6.45M | $118.56M |
Celldex Therapeutics, Inc. | CLDX | 5.32M | $198.07M |
Cogent Biosciences, Inc. | COGT | 3.67M | $141.92M |
Relay Therapeutics, Inc. | RLAY | 3.3M | $61.74M |
Cullinan Therapeutics, Inc. | CGEM | 3.11M | $56.71M |
Legend Biotech Corporation | LEGN | 3M | $86.67M |
Vaxcyte, Inc. | PCVX | 2.92M | $169.88M |
Vera Therapeutics, Inc. | VERA | 2.89M | $124.01M |
Beam Therapeutics Inc. | BEAM | 2.84M | $97.5M |
BioCryst Pharmaceuticals, Inc. | BCRX | 2.52M | $25.23M |
Travere Therapeutics, Inc. | TVTX | 2M | $113.62M |
Immunocore Holdings plc | IMCR | 1.38M | $43.66M |
Summit Therapeutics Inc. | SMMT | 1.2M | $17.48M |
Nurix Therapeutics, Inc. | NRIX | 1.19M | $28.98M |
Pharvaris N.V. | PHVS | 661.79K | $22.88M |
Amarin Corporation plc | AMRN | 532.98K | $8.5M |
Applied Aerospace & Defense, Inc. | AADX | 250K | $6.84M |
Insmed Incorporated | INSM | 100K | $10.66M |